|
A biomarker-driven strategy to guide the use of radiotherapy in non-small cell lung cancer
|
1R37CA222294-01A1
|
$366,000
|
|
ABAZEED, MOHAMED
|
CLEVELAND CLINIC LERNER COM-CWRU
|
|
Identifying molecular drivers of tumor heterogeneity in pancreatic cancer
|
1F31CA224792-01A1
|
$36,672
|
|
ADAMS, CHRISTINA
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Image-guided irreversible electroporation directed CAR T-cell delivery to solid tumors
|
1R01CA236615-01
|
$392,764
|
|
ADUSUMILLI, PRASAD
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Molecular mechanism of bitter melon juice efficacy against pancreatic cancer.
|
3R01CA195708-05S1
|
$94,087
|
|
AGARWAL, RAJESH
|
UNIVERSITY OF COLORADO DENVER
|
|
Network Lead Academic Participating Site: Memorial Sloan-Kettering Cancer Center
|
3U10CA180791-04S1
|
$145,357
|
|
AGHAJANIAN, CAROL
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Targeting galectin-3 to overcome drug resistance in metastatic prostate cancer therapy
|
1R43CA228813-01A1
|
$300,000
|
|
AHMED, HAFIZ
|
GLYCOMANTRA, INC.
|
|
Consolidated Basic Cancer Research Program
|
3P30CA010815-49S1
|
$142,498
|
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
Development of first-in-class histone acetyltransferase (HAT) activators for precision targeting of epigenetic derangements in lymphoma
|
1R01CA222931-01A1
|
$370,575
|
|
AMENGUAL, JENNIFER
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Womens Interagency HIV Study (WIHS-V)
|
3U01AI035004-25S1
|
$144,370
|
|
ANASTOS, KATHRYN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Resource stratified phased implementation frameworks to improve breast healthcare
|
1R13CA224776-01A1
|
$50,000
|
|
ANDERSON, BENJAMIN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Eco-Evolutionary dynamics of NSCLC to immunotherapy: Response and Resistance
|
1U01CA232382-01
|
$688,043
|
|
ANDERSON, ALEXANDER
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Targeting the adenosine A2A receptor immune checkpoint in lung cancer patients
|
3R01CA201124-03S1
|
$189,200
|
|
ANTONIA, SCOTT
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
FOXD3 up-regulation and ERBB3 signaling as an adaptive response to BRAF inhibitors in melanoma
|
2R01CA160495-06A1
|
$370,500
|
|
APLIN, ANDREW
|
THOMAS JEFFERSON UNIVERSITY
|
|
Cancer Genetics of Short Telomere Syndromes
|
1R01CA225027-01A1
|
$530,521
|
|
ARMANIOS, MARY
|
JOHNS HOPKINS UNIVERSITY
|
|
Targeting DOT1L for Degradation in MLL-rearranged Leukemia
|
2R01CA176745-07
|
$404,076
|
|
ARMSTRONG, SCOTT
|
DANA-FARBER CANCER INST
|
|
Predicting the Presence of Clinically Significant Prostate Cancer using Multiparametric MRI and MR-US Fusion Biopsy
|
1R21CA220352-01A1
|
$195,568
|
|
ARNOLD, COREY
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Role of HER2 mutations in breast cancer progression and response to targeted therapies
|
1R01CA224899-01A1
|
$382,641
|
|
ARTEAGA, CARLOS
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Gonadotropin Actions in Leydig Tumor Cells
|
5R01CA040629-27
|
$406,558
|
$101,640
|
Ascoli, Mario
|
UNIVERSITY OF IOWA
|
|
Ultrasound-based diagnostic and monitoring of bladder cancer treatment with drug released from nanoparticles
|
1R43CA232778-01
|
$295,240
|
|
ASSOULINE, JOE
|
NANOMEDTRIX, LLC
|
|
Cone Beam Tomosynthesis Fluoroscopy for Image Guided Interventions
|
3R43CA228158-01A1S1
|
$50,000
|
|
ATRIA, CRISTIAN
|
NVIEW MEDICAL, INC.
|
|
Genetic and Dietary Interactions in MMR Deficient Colon Tumorigenesis
|
1R01CA222358-01A1
|
$635,306
|
|
AUGENLICHT, LEONARD
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Nutrient Sensing and Transcriptional Regulation
|
1R01CA222650-01A1
|
$391,980
|
|
AYER, DONALD
|
UNIVERSITY OF UTAH
|
|
Obesity and Pancreatic Cancer Progression and Survival
|
1K07CA222159-01A1
|
$149,125
|
|
BABIC, ANA
|
DANA-FARBER CANCER INST
|
|
OLIGOSACCHARIDE STRUCTURE & FUNCTION IN RECOGNITION
|
5R01CA021923-32
|
$663,919
|
$331,960
|
BAENZIGER, JACQUES
|
WASHINGTON UNIVERSITY
|
|
Obesity, related comorbidities, and breast cancer outcomes in African Americans
|
3R01CA185623-05S1
|
$68,187
|
|
BANDERA, ELISA
|
RBHS -CANCER INSTITUTE OF NEW JERSEY
|
|
Bayesian learning algorithms for identifying and classifying heterogeneity of cell types in variety of solid tumors
|
1R21CA231892-01
|
$167,475
|
|
BANERJEE, ANJISHNU
|
MEDICAL COLLEGE OF WISCONSIN
|
|
Personalized Risk-AdaptIve Surveillance strategies in cancEr -- PRAISE
|
1R37CA218413-01A1
|
$414,368
|
|
BANSAL, AASTHAA
|
UNIVERSITY OF WASHINGTON
|
|
Contribution of development and age to breast cancer etiology
|
3R01CA190980-04S1
|
$58,563
|
|
BARCELLOS-HOFF, MARY
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Targeting the Major Histocompatibility Class I-LILRB1 signaling axis for cancer immunotherapy by macrophages
|
1F30CA232472-01
|
$43,039
|
|
BARKAL, AMIRA
|
STANFORD UNIVERSITY
|
|
Gaining Metabolic Insight in Older Men undergoing Androgen Deprivation Therapy for Prostate Cancer
|
1R01CA226211-01A1
|
$485,064
|
|
BASARIA, SHEHZAD
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cancer Center Support Grant
|
3P30CA042014-29S1
|
$125,000
|
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-29S2
|
$250,000
|
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-29S3
|
$248,625
|
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-29S4
|
$114,251
|
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA022453-36S1
|
$131,250
|
|
BEPLER, GEROLD
|
WAYNE STATE UNIVERSITY
|
|
A high efficiency imager for real-time lung cancer monitoring during radiotherapy
|
3R01CA188446-05S1
|
$256,320
|
|
BERBECO, ROSS
|
DANA-FARBER CANCER INST
|
|
Stem Cell/Nanoparticle Constructs for Targeted Ovarian Cancer Therapy
|
3R01CA197359-04S1
|
$68,577
|
|
BERLIN, JACOB
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Genomic Evaluation of the Female Survival Advantages in Melanoma
|
3P01CA206980-02S2
|
$75,897
|
|
BERWICK, MARIANNE
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
Translational Molecular and Cellular Imaging Technologies for Prostate Tumor Pathology
|
3R33CA196458-03S1
|
$66,508
|
|
BHARGAVA, ROHIT
|
UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN
|
|
Histone deacetylases 1,2 and DNA repair
|
3R01CA188520-04S1
|
$20,472
|
|
BHASKARA, SRIVIDYA
|
UNIVERSITY OF UTAH
|
|
Mitigating Long-term Treatment-related Morbidity in Childhood Cancer Survivors
|
1R35CA220502-01A1
|
$867,671
|
|
BHATIA, SMITA
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
COMPREHENSIVE CANCER CENTER CORE SUPPORT GRANT
|
3P30CA013148-46S1
|
$52,084
|
|
BIRRER, MICHAEL
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Imaging tumor and T cell responses to metabolic and immune modulation therapy
|
3R01CA215136-02S1
|
$70,499
|
|
BLASBERG, RONALD
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Integration of 3D primary tumor drug-profiling with patient-specific drug gene networks for recommending targeted cancer therapies (2 of 2).
|
3R21CA220398-02S1
|
$77,750
|
|
BOCA, SIMINA
|
GEORGETOWN UNIVERSITY
|
|
Chemical probes for specific targeting of matrix metallo proteases
|
3R01CA179253-05S1
|
$105,661
|
|
BOGYO, MATTHEW
|
STANFORD UNIVERSITY
|
|
Development of a Tumor-Specific PROTAC
|
1F31CA232477-01
|
$44,524
|
|
BOND, MICHAEL
|
YALE UNIVERSITY
|
|
Regulatory T Cell Control of Intestinal Tumorigenesis
|
3R01CA168670-05S1
|
$41,075
|
|
BOTHWELL, ALFRED
|
YALE UNIVERSITY
|
|
Radiogenomic tools for prediction of breast cancer neo-adjuvant chemotherapy response from pre-treatment MRI
|
1F31CA221383-01A1
|
$42,074
|
|
BRAMAN, NATHANIEL
|
CASE WESTERN RESERVE UNIVERSITY
|
|
The power of extracellular vesicles in glioblastoma
|
1R35CA232103-01
|
$935,071
|
|
BREAKEFIELD, XANDRA
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Late Effects of Treatment in Wilms Tumor Survivors and Offspring
|
5R01CA054498-19
|
$1,041,309
|
$208,262
|
BRESLOW, NORMAN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
Total relevant funding to Contraception and Reproduction Research for this search: $2,567,725
|